BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Total Assets (Quarterly) : 4.755M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.755M |
| March 31, 2026 | 1.712M |
| December 31, 2025 | 3.413M |
| September 30, 2025 | 6.148M |
| June 30, 2025 | 2.089M |
| March 31, 2025 | 2.166M |
| December 31, 2024 | 3.724M |
| September 30, 2024 | 6.267M |
| June 30, 2024 | 2.89M |
| March 31, 2024 | 2.679M |
| December 31, 2023 | 2.987M |
| September 30, 2023 | 3.747M |
| June 30, 2023 | 6.389M |
| March 31, 2023 | 7.128M |
| December 31, 2022 | 9.793M |
| September 30, 2022 | 9.179M |
| June 30, 2022 | 11.27M |
| March 31, 2022 | 12.84M |
| December 31, 2021 | 15.72M |
| September 30, 2021 | 17.33M |
| June 30, 2021 | 20.22M |
| March 31, 2021 | 23.31M |
| December 31, 2020 | 23.42M |
| September 30, 2020 | 9.502M |
| June 30, 2020 | 13.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.384M |
| December 31, 2019 | 7.678M |
| September 30, 2019 | 10.68M |
| June 30, 2019 | 2.716M |
| March 31, 2019 | 5.157M |
| December 31, 2018 | 6.417M |
| September 30, 2018 | 5.556M |
| June 30, 2018 | 7.661M |
| March 31, 2018 | 10.41M |
| December 31, 2017 | 13.54M |
| September 30, 2017 | 15.86M |
| June 30, 2017 | 17.76M |
| March 31, 2017 | 19.78M |
| December 31, 2016 | |
| September 30, 2016 | 19.48M |
| June 30, 2016 | 14.02M |
| March 31, 2016 | 13.95M |
| December 31, 2015 | 13.88M |
| September 30, 2015 | 13.78M |
| June 30, 2015 | 13.70M |
| March 31, 2015 | 13.62M |
| December 31, 2014 | 13.54M |
| September 30, 2014 | 13.49M |
| June 30, 2014 | 13.44M |
| March 31, 2014 | 13.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.925B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.055M |
| Shareholders Equity (Quarterly) | 2.70M |
| Debt to Equity Ratio | 0.1085 |
| Current Ratio | 2.092 |
| Net Debt Paydown Yield | 0.60% |